These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2436231)

  • 1. A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope.
    Palker TJ; Matthews TJ; Clark ME; Cianciolo GJ; Randall RR; Langlois AJ; White GC; Safai B; Snyderman R; Bolognesi DP
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2479-83. PubMed ID: 2436231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.
    Palker TJ; Clark ME; Langlois AJ; Matthews TJ; Weinhold KJ; Randall RR; Bolognesi DP; Haynes BF
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1932-6. PubMed ID: 2450351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.
    Goudsmit J; Debouck C; Meloen RH; Smit L; Bakker M; Asher DM; Wolff AV; Gibbs CJ; Gajdusek DC
    Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4478-82. PubMed ID: 2454471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus.
    Montelaro RC; Robey WG; West MD; Issel CJ; Fischinger PJ
    J Gen Virol; 1988 Jul; 69 ( Pt 7)():1711-7. PubMed ID: 2839603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4.
    Skinner MA; Langlois AJ; McDanal CB; McDougal JS; Bolognesi DP; Matthews TJ
    J Virol; 1988 Nov; 62(11):4195-200. PubMed ID: 2845130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes.
    Palker TJ; Matthews TJ; Langlois A; Tanner ME; Martin ME; Scearce RM; Kim JE; Berzofsky JA; Bolognesi DP; Haynes BF
    J Immunol; 1989 May; 142(10):3612-9. PubMed ID: 2469721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins.
    Ho DD; Sarngadharan MG; Hirsch MS; Schooley RT; Rota TR; Kennedy RC; Chanh TC; Sato VL
    J Virol; 1987 Jun; 61(6):2024-8. PubMed ID: 2437327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein.
    Wang JJ; Steel S; Wisniewolski R; Wang CY
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6159-63. PubMed ID: 2426711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.
    Neurath AR; Strick N; Lee ES
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological reactivity of a human immunodeficiency virus type I derived peptide representing a consensus sequence of the GP120 major neutralizing region V3.
    Wagner R; Modrow S; Böltz T; Fliessbach H; Niedrig M; von Brunn A; Wolf H
    Arch Virol; 1992; 127(1-4):139-52. PubMed ID: 1456889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization.
    Ho DD; Kaplan JC; Rackauskas IE; Gurney ME
    Science; 1988 Feb; 239(4843):1021-3. PubMed ID: 2830667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160.
    Benjouad A; Gluckman JC; Montagnier L; Bahraoui E
    J Virol; 1993 Mar; 67(3):1693-7. PubMed ID: 7679751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition.
    Vahlne A; Horal P; Eriksson K; Jeansson S; Rymo L; Hedström KG; Czerkinsky C; Holmgren J; Svennerholm B
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10744-8. PubMed ID: 1961741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses.
    Nara PL; Robey WG; Arthur LO; Asher DM; Wolff AV; Gibbs CJ; Gajdusek DC; Fischinger PJ
    J Virol; 1987 Oct; 61(10):3173-80. PubMed ID: 2442411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
    Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
    J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects.
    Klasse PJ; Pipkorn R; Blomberg J
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5225-9. PubMed ID: 2455899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralizing monoclonal antibodies against human immunodeficiency virus type 2 gp120.
    Matsushita S; Matsumi S; Yoshimura K; Morikita T; Murakami T; Takatsuki K
    J Virol; 1995 Jun; 69(6):3333-40. PubMed ID: 7538171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of anti-HIV neutralizing antibodies by synthetic peptides.
    Chanh TC; Dreesman GR; Kanda P; Linette GP; Sparrow JT; Ho DD; Kennedy RC
    EMBO J; 1986 Nov; 5(11):3065-71. PubMed ID: 3466790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide.
    Cease KB; Margalit H; Cornette JL; Putney SD; Robey WG; Ouyang C; Streicher HZ; Fischinger PJ; Gallo RC; DeLisi C
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4249-53. PubMed ID: 2438696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1.
    Linsley PS; Ledbetter JA; Kinney-Thomas E; Hu SL
    J Virol; 1988 Oct; 62(10):3695-702. PubMed ID: 2458487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.